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The use of CT and MRI allows the pattern of multiple brain lesions to be determined in patients with a neurological focal deficit or with symptoms of intracranial hypertension.
Most of these patients could be diagnosed correctly regarding the nature of their intracranial lesions after clinical and laboratory findings as in multiple sclerosis, in secondary infective and parasitic diseases, in metastatic tumours, and in the brain localisations of systemic diseases. Nevertheless, in some cases the multiple lesions detected by CT and MRT remain the only demonstrable evidence of the illness and treatment may be planned only on the presumptive diagnosis.
The usefulness of stereotactic procedures to detect the nature of the lesions and decide treatment is discussed based on our experience of 100 consecutive patients operated on at the National Neurological Institute of Milan. Materials and methods Between 1978 and 1991 940 patients underwent stereotactic serial biopsy for brain lesions. One hundred patients out of these series were affected by multiple intracerebral lesions. They were selected for stereotactic biopsy based on the following criteria:
(1) They had no neoplasms outside the nervous system.
(2) They had no systemic diseases possibly related to the brain localisations.
(3) There were no disorders of the cerebral circulation and no evidence of demyelinating diseases of the nervous system. (4) They had a CT and MRI pattern suggesting different aetiologies in regard to the nature of the lesions.
(5) Neurological and general conditions still allowed a therapeutic choice (Karnofsky stage >70) . ' The ages of these cases ranged from 7 to 66 (mean age 51); 67 were caucasian males. The heralding symptoms included intracranial hypertension in 60 cases, focal neurological deficits in 26 cases, and epileptic seizures in 14 cases. Only in two patients the clinical picture suggested the presence of multiple focal lesions before neuroradiological examinations. Until 1985 the radiological diagnosis was achieved by CT and then by CT and MRI. The number of radiologically demonstrated lesions ranged from two to eight (mean four) in each patient. In 85 patients the lesions were only supratentorial whereas in the other cases the cerebellum and the brainstem were also involved. In 75 cases lesions were localised on both sides. Preliminary corticosteroid treatment (4 mg dexamethazone thrice daily) was performed in all cases to treat intracranial hypertension and oedema around the lesion, and to rule out primary brain lymphoma.
The stereotactic biopsy was performed with different frames including Riechert, BRW, CRW, Zeppelin, and Leksell systems and since 1986 was assisted by three dimensional computerised reconstruction of CT or MRI 
Results
Thirty seven patients had malignant multifocal gliomas including anaplastic astro- The table summarises the histological diagnoses obtained in the whole series.
The choice of treatment was guided by the histological findings. Multifocal malignant gliomas were treated by chemotherapy with cisplatin, carmustine, and etoposide'9 20 and conventional radiotherapy (6000 rads)21' 23; the survival in these patients ranged between four and 18 (mean nine) months as in patients affected by single malignant non-operated gliomas.
Multiple primitive brain lymphomas were treated by chemotherapy with methotrexate, vincristine, and carmustine24 and external radiotherapy; the survival ranged between 16 months and five years (mean three years).
Metastatic tumours were treated by external brain radiotherapy only (6000 rads). These patients were also investigated for the primary tumours outside the nervous system. The origin of brain metastatic tumours was found in only two cases out of 14. Survival ranged between five and 24 (mean seven) months.
Germinomas were treated by radiotherapy; complete clinical and radiological recovery was obtained in one case (four year follow up) whereas in the other patient early dissemination occurred with fatal recurrence of the disease despite the similar histological findings. Multifocal primitive neuroepithelial tumours were treated as malignant gliomas, with poor results. The patient affected by multiple teratoma underwent chemotherapy with platinex, vepesid, and bleomicine, and external radiotherapy to the whole brain and spinal axis with radiological reduction of the lesions; this patient is still disease free at a three year follow up.
Patients with multiple strokes were given pharmacological treatment with ticlopidine after ruling out microembolic peripheral sources in the heart and supra-ortic vessels. One patient with gliovascular haemorrhagic dysplasias died within one year after the biopsy due to lesion rebleeding; the second patient is still alive but has complained of progressive worsening without major haemorrhage.
Patients with multiple primary cerebral abscesses were treated by stereotactic aspiration of major lesions and repeated intracavitary and systemic antibiotic treatment. 14 All patients recovered and are still doing well at three to eight year follow up. Patients with multifocal viral encephalitis and by primitive neuroepithelial tumours had fatal outcomes within four months of stereotactic biopsy. Figures 1-7 show neuroradiological patterns.
Role of stereotactic biopsy in multifocal brain lesions: considerations on 100 consecutive cases In patients affected by neoplasms the correct histological diagnosis contributed to the evaluation of life expectancy-that is, in brain lymphomas v malignant gliomas.
In the near future, the extensive utilisation of stereotactic radiosurgery and combined surgical and radiosurgical treatment of multiple metastatic tumours25-27 will considerably boost the need of preoperative histological diagnosis in multifocal brain lesions.
In conclusion, stereotactic biopsy may be considered the first step in the treatment of multiple brain lesions when the selection criteria that characterise the reported series of patients are fulfilled.
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